TickerFactsScreenerDevelopers

Spyre Therapeutics, Inc. (SYRE) — Net Income

Annual figures by fiscal year, from SEC filings.

2014: -$10.35M2015: -$11.29M2016: -$21.70M2017: -$27.24M2018: -$44.35M2019: -$78.25M2020: -$80.89M2021: -$65.80M2022: -$83.81M2023: -$338.79M2024: -$208.02M2025: -$155.20M-$155.20M
2014Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$155.20M+25.4%
2024-$208.02M+38.6%
2023-$338.79M-304.2%
2022-$83.81M-27.4%
2021-$65.80M+18.7%
2020-$80.89M-3.4%
2019-$78.25M-76.5%
2018-$44.35M-62.8%
2017-$27.24M-25.5%
2016-$21.70M-92.1%
2015-$11.29M-9.2%
2014-$10.35M—